Measured Wealth Private Client Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Measured Wealth Private Client Group's LLY Position: Q1 2026 in Review
Measured Wealth Private Client Group reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $5.07K and leaving 114 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #230.
Measured Wealth Private Client Group first reported a position in LLY in Q3 2018 and has held it in 24 quarters since. The position peaked at $917K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Measured Wealth Private Client Group held 114 shares of Eli Lilly worth $105K as of Q1 2026.
- Measured Wealth Private Client Group sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
- Eli Lilly made up 0.03% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #230 holding.
- Measured Wealth Private Client Group first reported a position in Eli Lilly in Q3 2018 and has held it in 24 quarters since.
- Measured Wealth Private Client Group's Eli Lilly position peaked at $917K in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.